SOLO 12/17/2020

 

VSTM

 

FSR

 

EOLS

 

INPIXON FILL THE SHORT

QTEK 55.67% DOWN  1: 50 FILL THE SHORT

ID	stock	number	price	TOTAL PRICE	plan	current price	NUMBER OF SHARE	current lost price	net loss	fill amount	filled price	fill total	grand total	grand share	grand avg	GAP
7	QTEK	$1.00	$0.88	$0.88		$0.39	$1.00	$0.39	($0.49)	$50.00	$0.39	$19.50	$20.38	$51.00	$0.40

 

 ATNF(TD) 82.17 % DOWN FILL THE SHORT 800  ( 1:800SHARE TO FILL FOR 82% DOWN ) 

ST

ID	stock	number	price	Field1	plan	current price	share amount	current lost price	net loss	fill amount	filled price	fill total	grand total	grand share	grand avg	GAP
5	ATNF	$1.00	$11.83	$11.83		$2.11	$1.00	$2.11	($9.72)	$800.00	$2.11	$1,688.00	$1,699.83	$801.00	$2.12

FILL THE SHORT

ID	stock	broker	amount	AVG	BUY TOTAL	date	time	Filled price	amount filled	volume	Total filled	total Stock	Total $	final price	Remark
86	INPX		7	$13.02	$91.14			$1.86	1,000.00	0	$1,860.00	1007	$1,951.14	$1.94
87	INPC		12	$20.49	$245.82			$1.86	1,200.00	0	$2,232.00	1212	$2,477.82	$2.04

STOCK -FILL THE SHORT TABLE

ID	STOCK	REMARK PRICE	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
243	INPX		RH	$1.12	2188	$2,450.56	1000	$0.98	$980.00	$3,430.56	3188	$1.08	0

STOCK -FILL THE SHORT TABLE

ID	STOCK	REMARK PRICE	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
242	INPX		RH	$1.12	2188	$2,450.56	1000	$1.00	$1,000.00	$3,450.56	3188	$1.08	0

ZOM FILL THE SHORT

 

STOCK -FILL THE SHORT TABLE

ID	STOCK	REMARK PRICE	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
238	zom		RH	$0.18	1200	$221.28	1000	$0.15	$151.70	$372.98	2200	$0.17	0

News Highlights: Top Company News of the Day

 

News Highlights: Top Company News of the Day

Today 7:00 AM ET (Dow Jones)Print

 
FDA Panel Expected to Back Moderna Covid-19 Vaccine 
 

The agency's advisory committee is likely to recommend an emergency use authorization for the new vaccine from Moderna when the panel meets Thursday, its chairman said.

 
Rio Tinto Names Stausholm New CEO, as It Seeks to Rebuild Reputation 
 

Rio Tinto has promoted Jakob Stausholm to CEO as the miner battles to repair its reputation with investors, lawmakers and indigenous groups after the destruction of two ancient rock shelters in Australia earlier this year.

 
Toyota's Chief Says Electric Vehicles Are Overhyped 
 

Toyota Motor's leader criticized what he described as excessive hype over electric vehicles, saying advocates failed to consider the carbon emitted by generating electricity and the costs of an EV transition.

 
Novartis to Buy Cadent Therapeutics 
 

Novartis has agreed to buy Massachusetts-based neuroscience company Cadent Therapeutics for an upfront fee of $210 million and additional milestone payments totaling $560 million.

 
TalkTalk Agrees to Toscafund Takeover 
 

TalkTalk has accepted a GBP1.1 billion takeover by Toscafund Asset Management, the telecom group's second biggest shareholder.

 
Peter Jackson's Special-Effects Firm Looks to Become a Content Producer 
 

At a time when much of Hollywood is reeling from Covid-19, Weta Digital, the visual-effects company behind "Avatar" and "Avengers: End Game," is looking to pull a growth story out of its magic hat.

 
Amazon Faces Union Push in Alabama 
 

Election to be scheduled for workers at the company's Bessemer facility, the first such election since 2014 at the nation's second-largest employer.

 
BarkBox to Go Public in $1.6 Billion Deal 
 

The dog-supplies startup is the latest company to go public by merging with a blank-check company.

 
NASA Makes Blue Origin Eligible to Launch Future Missions Without Crews 
 

Jeff Bezos and his company's New Glenn rocket, which hasn't yet flown, received the nod to potentially carry scientific payloads later this decade.

 
Google Is Accused of Enlisting Facebook to Aid in Ad-Rigging 
 

A Texas-led antitrust case accuses the search giant of manipulating digital advertising markets, in part through an alleged agreement with rival Facebook aimed at preserving Google's dominance.

(END) Dow Jones Newswires

December 17, 2020 07:00 ET (12:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

12 Information Technology Stocks Moving In Wednesday's After-Market Session

 

12 Information Technology Stocks Moving In Wednesday's After-Market Session

12/16/20 4:38 PM ET (Benzinga)Print

Gainers

Steel Connect (NASDAQ:STCN) stock rose 4.87% to $0.86 during Wednesday's after-market session. Steel Connect's trading volume hit 400 shares by close, accounting for 0.28% of its average volume over the last 100 days. The company's market cap stands at $54.0 million.

Veeco Instruments (NASDAQ:VECO) stock rose 4.16% to $18.99. Today's trading volume for this security ended up closing at 53.6K shares, which is 11.09 percent of its average volume over the last 100 days. The company's market cap stands at $942.1 million.

Siyata Mobile (NASDAQ:SYTA) shares increased by 3.8% to $10.9. Trading volume for this security closed at 1.7K, accounting for 2.35% of its average full-day volume over the last 100 days. The company's market cap stands at $35.7 million.

Usio (NASDAQ:USIO) stock moved upwards by 3.51% to $2.06. At the close, Usio's trading volume reached 1.5K shares. This is 0.67% of its average volume over the last 100 days. The market value of their outstanding shares is at $51.0 million.

Verb Tech (NASDAQ:VERB) shares increased by 3.26% to $1.58. Verb Tech's trading volume hit 7.0K shares by close, accounting for 1.42% of its average volume over the last 100 days. The company's market cap stands at $77.9 million.

Cheetah Mobile (NYSE:CMCM) shares moved upwards by 1.99% to $2.05. Today's trading volume for this security ended up closing at 2.7K shares, which is 0.88 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $286.6 million.

Losers

MMTEC (NASDAQ:MTC) stock fell 3.29% to $1.47 during Wednesday's after-market session. This security traded at a volume of 3.1K shares come close, making up 0.09% of its average volume over the last 100 days. The market value of their outstanding shares is at $30.6 million.

Phunware (NASDAQ:PHUN) shares decreased by 3.23% to $0.94. At the close, Phunware's trading volume reached 1.7 million shares. This is 68.4% of its average volume over the last 100 days. The company's market cap stands at $46.2 million.

Powerbridge Technologies (NASDAQ:PBTS) shares decreased by 2.76% to $2.12. Powerbridge Technologies's trading volume hit 2.0K shares by close, accounting for 4.32% of its average volume over the last 100 days. The company's market cap stands at $97.0 million.

MICT (NASDAQ:MICT) shares fell 2.69% to $1.81. MICT's trading volume hit 6.6K shares by close, accounting for 0.98% of its average volume over the last 100 days. The market value of their outstanding shares is at $124.1 million.

i3 Verticals (NASDAQ:IIIV) shares decreased by 2.22% to $30.0. i3 Verticals's trading volume hit 16.8K shares by close, accounting for 8.48% of its average volume over the last 100 days. The market value of their outstanding shares is at $924.6 million.

GreenSky (NASDAQ:GSKY) stock fell 2.11% to $4.19. Today's trading volume for this security ended up closing at 74.6K shares, which is 7.79 percent of its average volume over the last 100 days. The company's market cap stands at $765.0 million.

PDATE: Allergic reaction to COVID-19 vaccine reported in Alaska

PDATE: Allergic reaction to COVID-19 vaccine reported in Alaska

Today 7:42 AM ET (MarketWatch)

Share

Print

Health officials in Alaska said Wednesday that a health care worker who had received one dose of BioNTech (BNTX) and Pfizer Inc.'s (PFE) COVID-19 vaccine had a "presumed allergic reaction." The individual, who did not have a history of allergies,

 reported flushing and shortness of breath within 10 minutes of receiving the vaccine and is currently hospitalized

. U.K. officials last week said there had been two instances of anaphylactic reaction (http://www.marketwatch.com/story/u-k-regulators-warn-people-with-history-of-significant-allergic-reactions-not-to-have-pfizerbiontech-covid-19-vaccine-after-two-adverse-reactions-11607514857%7CNEW) among the first group of people to start receiving the shots there.

 Hospitals in Alaska began administering doses of the BioNTech/Pfizer vaccine on Tuesday, four days after the Food and Drug Administration granted emergency authorization to the vaccine, making it the first coronavirus vaccine to be made available to people in the U.S. "We expected that a side effect like this could occur," Dr. Anne Zink, chief medical officer for the state, said in a news release. "All sites that are approved to provide vaccinations in Alaska must have medications on hand to deal with an allergic reaction."

-Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com

42 Stocks Moving in Thursday's Pre-Market Session

 

42 Stocks Moving in Thursday's Pre-Market Session

Today 7:01 AM ET (Benzinga)Print

Gainers

• Oriental Culture Holding LTD (NASDAQ: OCG) rose 110.5% to $12.84 in pre-market trading. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
• Scopus BioPharma Inc. (NASDAQ: SCPS) rose 70.4% to $10.09 in pre-market trading. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.
• Nxt-ID, Inc. (NASDAQ: NXTD) rose 48.3% to $1.37 in pre-market trading after jumping around 90% on Wednesday.
• Wunong Net Technology Company Limited (NASDAQ: WNW) shares rose 30.1% to $84.68 in pre-market trading after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.
• Marathon Patent Group, Inc.. (NASDAQ: MARA) rose 22.8% to $10.10 in pre-market trading after surging 16% on Wednesday.
• Canaan Inc. (NASDAQ: CAN) rose 18.7% to $4.51 in pre-market trading after gaining around 7% on Wednesday.
• 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 17.3% to $0.8855 in pre-market trading. OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in 9 Meters Biopharma.
• Vivos Therapeutics, Inc. (NASDAQ: VVOS) rose 16.7% to $7.91 in pre-market trading. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
• Bit Digital, Inc. (NASDAQ: BTBT) shares rose 16.4% to $5.88 in pre-market trading following an 18% decline on Wednesday. Bit Digital, earlier during the month, highlighted completion of acquisition of $13,902,742 worth of bitcoin miners with total hash rate of 1,003.5 Ph/s.
• ORBCOMM Inc. (NASDAQ: ORBC) shares rose 16.3% to $7.79 in pre-market trading. ORBCOM, last week, won a $45.6 million contractfFrom the Department of Army titled 'Next Generation Transponder.'
• Skillful Craftsman Education Technology Limited (NASDAQ: EDTK) rose 16% to $3.36 in pre-market trading.
• MacroGenics, Inc. (NASDAQ: MGNX) rose 15.8% to $28.60 in pre-market trading after the company announced FDA approval of MARGENZA for patients with pretreated metastatic HER2-positive breast cancer.
• Celsion Corporation (NASDAQ: CLSN) rose 11.9% to $0.7495 in pre-market trading after declining over 5% on Wednesday.
• NeuroMetrix, Inc. (NASDAQ: NURO) rose 11.9% to $2.91 in pre-market trading after declining 8% on Wednesday. The company was recently granted U.S. patent titled 'Transcutaneous electrical nerve stimulation using novel unbalanced biphasic waveform and novel electrode arrangement.'
• Atossa Therapeutics, Inc. (NASDAQ: ATOS) shares rose 11.5% to $1.07 in pre-market trading after gaining around 10% on Wednesday. Atossa Therapeutics, last week, priced a $20 million underwritten public offering.
• Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 10.8% to $11.35 in pre-market trading. Enlivex, earlier during the month, reported issuance of new Chinese patent covering allocetra immunotherapy.
• Farmmi, Inc. (NASDAQ: FAMI) rose 10.2% to $1.41 in pre-market trading after gaining over 8% on Wednesday. Farmmi subsidiary Zhejiang Forest Food, on Monday, received an order for sliced black fungus and tea tree mushrooms.
• CHF Solutions, Inc. (NASDAQ: CHFS) rose 10.2% to $8.98 in pre-market trading after gaining over 6% on Wednesday.
• Ebang International Holdings Inc. (NASDAQ: EBON) shares rose 10.1% to $4.70 in pre-market trading after gaining over 6% on Wednesday.
• Riot Blockchain, Inc. (NASDAQ: RIOT) rose 9.8% to $11.81 in pre-market trading. Riot Blockchain shares also jumped around 6% on Wednesday amid recent strength in Bitcoin prices.
• MicroStrategy Incorporated (NASDAQ: MSTR) rose 8.7% to $325.00 in pre-market trading amid rise in Bitcoin prices.
• Evolus, Inc. (NASDAQ: EOLS) rose 8.2% to $3.97 in pre-market trading after the company issued an update on United States International Trade Commission (ITC) case.
• Arbutus Biopharma Corporation (NASDAQ: ABUS) rose 8% to $4.76 in pre-market trading after dropping 11% on Wednesday. Arbutus Biopharma, last week, announced additional clinical data from an ongoing Phase 1a/1b clinical trial with AB-729.
• Roku, Inc. (NASDAQ: ROKU) rose 6.5% to $346.90 in pre-market trading. Roku is partnering with AT&T’s subscription video-on-demand streaming service HBO Max starting Thursday.
• Neos Therapeutics, Inc. (NASDAQ: NEOS) rose 6.5% to $0.72 in pre-market trading. Neos Therapeutics and Aytu Biosciences last week announced a merger agreement.
• Accenture plc (NYSE: ACN) rose 4.6% to $258.88 in pre-market trading after the company reported upbeat Q1 results and issued strong Q2 sales forecast.
• Lennar Corporation (NYSE: LEN) rose 3.8% to $77.09 in pre-market trading following upbeat quarterly earnings.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• SCYNEXIS, Inc. (NASDAQ: SCYX) fell 19.6% to $5.90 in pre-market trading after the company announced the launch of $50 million common stock and warrant offering.
• Apollo Endosurgery, Inc. (NASDAQ: APEN) shares fell 11.7% to $3.51 in pre-market trading. Apollo Endosurgery, on Wednesday, announced it received FDA clearance for the X-Tack Endoscopic HeliX Tacking System.
• CureVac N.V. (NASDAQ: CVAC) fell 11.8% to $102.54 in pre-market trading. CureVac recently announced the commencement of its global pivotal Phase2b/3 trial for its Covid-19 vaccine candidate CVnCoV.
• Uxin Limited (NASDAQ: UXIN) fell 11.6% to $1.24 in pre-market trading after reporting Q2 results.
• MiMedx Group, Inc. (NASDAQ: MDXG) fell 10.6% to $7.00 in pre-market trading. MiMedx Group shares jumped 19% on Wednesday after Prescience Point Capital Management, a company shareholder, gave bullish commentary on the stock and issued a $31 price target.
• SG Blocks, Inc. (NASDAQ: SGBX) fell 10.4% to $3.55 in pre-market trading. SG Blocks, on Tuesday, said it sees FY21 gross revenue of $20 million.
• Zedge, Inc. (NYSE: ZDGE) fell 8% to $4.92 in pre-market trading. Zedge, last week, posted upbeat quarterly results.
• Liquidia Corporation (NASDAQ: LQDA) fell 7.9% to $2.81 in pre-market trading as the company filed for mixed shelf of up to $200 million.
• Mid-Con Energy Partners, LP (NASDAQ: MCEP) fell 7.3% to $3.04 in pre-market trading after declining around 22% on Wednesday.
• Aethlon Medical, Inc. (NASDAQ: AEMD) fell 7.1% to $2.10 in pre-market trading. Aethlon Medical shares jumped over 40% on Wednesday after the company treated the first patient in its first-in-human Early Feasibility Study of the HEMOPURIFIER.
• OrganiGram Holdings Inc. (NASDAQ: OGI) shares fell 7% to $1.33 in pre-market trading. Organigram, on Wednesday, launched new 1g Trailblazer Torch Vape cartridges.
• Heat Biologics, Inc. (NASDAQ: HTBX) fell 6.6% to $5.51 in pre-market trading. Heat Biologics shares climbed around 10% on Wednesday after the company announced completion of ZVX-60 vaccine cell line for COVID-19.
• Allied Esports Entertainment Inc. (NASDAQ: AESE) fell 5.6% to $1.51 in pre-market trading. Allied Esports, on Wednesday, launches 24-hour cross-channel content strategy on Twitch.
• Qutoutiao Inc. (NASDAQ: QTT) fell 5.6% to $2.36 in pre-market trading following Q3 results.
• ABM Industries, Inc. (NYSE: ABM) fell 4.1% to $38.70 in pre-market trading as the company after the company announced downbeat quarterly earnings.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Back to News Overview